OTTAWA – The weekly arrival of more than two million doses of the Pfizer-BioNTech vaccine is due to begin in Canada this week.
Since mid-March, pharmaceutical companies Pfizer and BioNTech have been able to ship approximately one million doses to Canada each week made at a factory in the Brussels region of Belgium, but the number is expected to double as of this date. week before increasing again in June.
Doses are also due to come from the United States this week, from Pfizer’s plant in Kalamazoo, Michigan.
So far, the US government has placed limits on the export of vaccine doses so that its own citizens are inoculated first.
Nothing new has so far been announced by the Government of Canada on the arrival from the United States of new doses of the Oxford-AstraZeneca vaccine, which has not yet received the approval of the American authorities of the health.
Demand for the Oxford-AstraZeneca vaccine has exploded in Canada since provinces lowered the eligibility age to receive it to 40; in Quebec, the minimum age has been set at 45 years.
As for the manufacturer Moderna, it must send to Canada more than a million doses of its vaccine during the next week.
The first 300,000 doses of Johnson & Johnson arrived in Canada last week, but federal authorities have yet to approve their use after around 15 million doses were in trouble production at a plant in Maryland.
Health Canada does not believe that the doses sent into the country were linked to this plant.
As of Sunday, more than 173,000 vaccinations had been made in Canada, bringing the total doses injected to 13,825,476.
–
